Immunology

News from the FDA/CDC

New meningococcal vaccine wins FDA approval

The vaccine “has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest...

Commentary

Atopic dermatitis: Five things to know

The incidence of AD has increased over the past several decades, and environmental factors such as climate change have been implicated as a...

News from the FDA/CDC

FDA approves first tocilizumab biosimilar

Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.

Pages